Source: International Congress 2018 – Diagnosis of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Öcal (Istanbul, Turkey), P. Etiz (Adana, Turkey), Z. Bingol (Istanbul, Turkey), O. Koksalan (Istanbul, Turkey), Z. Kilicaslan (Istanbul, Turkey). Patients with recurrent tuberculosis in Istanbul: reactivation?, reinfection?. 4765

Member's Comments

No comment yet.

Related content which might interest you: The cases of active tuberculosis among persons with latent tuberculosis infection residing in the disease hot spots Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Extrapulmonary tuberculosis in HIV infected patients admitted to the hospital Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 How should we treat latent tuberculosis infection? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 Differences in the manegement of latent tuberculosis infection in patients treated with anti-TNF-α in Turkey Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 Recurrent tuberculosis among HIV infected persons in Singapore Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Should patients with active tuberculosis be routinely screened for chronic viral hepatitis? Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible? Source: International Congress 2015 – Paediatric bronchology Year: 2015 Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Is it just an infection? Source: Breathe, 14 (3) e100; 10.1183/20734735.021518 Year: 2018 Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Risk of developing active TB in children with latent TB infection Source: International Congress 2015 – Screening strategies in TB Year: 2015 Antifungals in pulmonary infections: to whom, when and how? Source: Eur Respir Monogr 2017; 75: 159-184 Year: 2017 The diagnosis of latent tuberculosis infection in children with new immunologic tests Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Screening for tuberculosis in patients with COVID-19 infection in Georgia. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands Source: Eur Respir J 2016; 48: 1420-1428 Year: 2016 Tuberculosis in the immunocompromised host: atypical TB? Source: Annual Congress 2006 - PG11 - Clinical highlights on tuberculosis Year: 2006 Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Untreatable tuberculosis: is surgery the answer? Source: Eur Respir J 2015; 45: 577-582 Year: 2015 Active tuberculosis prevalence and characteristics of tuberculosis patients in liver transplant patients Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 How long do patients with pulmonary tuberculosis remain smear and culture positive? Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013